A follow-up report on potential drug interactions with clementines: two single case experiments show no effect on CYP3A-dependent midazolam clearance

Abstract: We have previously demonstrated that clementines have in vitro drug interaction potential. To assess the clinical relevance of clementine-drug interaction, two single case experiments with repetitive phenotyping of CYP3A activity were conducted. Although an increment of 43% in the estimate...

Full description

Saved in:
Bibliographic Details
Main Authors: Hohmann, Nicolas (Author) , Mikus, Gerd (Author) , Haefeli, Walter E. (Author) , Schwenger, Vedat (Author) , Weiß, Johanna (Author)
Format: Article (Journal)
Language:English
Published: 15 May 2019
In: European journal of pharmaceutical sciences
Year: 2019, Volume: 133, Pages: 54-58
ISSN:1879-0720
DOI:10.1016/j.ejps.2019.03.013
Online Access:Verlag, Volltext: https://doi.org/10.1016/j.ejps.2019.03.013
Get full text
Author Notes:Nicolas Hohmann, Gerd Mikus, Walter Emil Haefeli, Vedat Schwenger, Giuseppe Gattuso, Davide Barreca, Johanna Weiss

MARC

LEADER 00000caa a2200000 c 4500
001 1671404386
003 DE-627
005 20220816210055.0
007 cr uuu---uuuuu
008 190814s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejps.2019.03.013  |2 doi 
035 |a (DE-627)1671404386 
035 |a (DE-599)KXP1671404386 
035 |a (OCoLC)1341235715 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hohmann, Nicolas  |d 1983-  |e VerfasserIn  |0 (DE-588)1018788999  |0 (DE-627)683426052  |0 (DE-576)356371816  |4 aut 
245 1 2 |a A follow-up report on potential drug interactions with clementines  |b two single case experiments show no effect on CYP3A-dependent midazolam clearance  |c Nicolas Hohmann, Gerd Mikus, Walter Emil Haefeli, Vedat Schwenger, Giuseppe Gattuso, Davide Barreca, Johanna Weiss 
264 1 |c 15 May 2019 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.08.2019 
520 |a Abstract: We have previously demonstrated that clementines have in vitro drug interaction potential. To assess the clinical relevance of clementine-drug interaction, two single case experiments with repetitive phenotyping of CYP3A activity were conducted. Although an increment of 43% in the estimated midazolam clearance (eCLmet) was observed during the first experiment in a renal transplant patient on tacrolimus after 4-d consumption of clementines (1kg/d), and an increment of +89% of eCLmet was observed during chronic consumption of clementine juice in a healthy male volunteer, these changes lie within the range of intra-individual variability. Therefore one cannot assure a potential drug interaction due to the clementines, but prescribers should be cautious unless further data emerges. In contrast to the juice used for the in vitro assay comprising several flavonoids, this juice only contained hesperidin and narirutin indicating that the drug interactions potential of clementines might depend on the composition varying from batch to batch 
700 1 |a Mikus, Gerd  |e VerfasserIn  |0 (DE-588)110903137  |0 (DE-627)691097941  |0 (DE-576)336988710  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
700 1 |a Schwenger, Vedat  |e VerfasserIn  |0 (DE-588)1022867652  |0 (DE-627)717320197  |0 (DE-576)176592237  |4 aut 
700 1 |a Weiß, Johanna  |e VerfasserIn  |0 (DE-588)1050230906  |0 (DE-627)783666322  |0 (DE-576)404441114  |4 aut 
773 0 8 |i Enthalten in  |t European journal of pharmaceutical sciences  |d New York, NY [u.a.] : Elsevier, 1993  |g 133(2019), Seite 54-58  |h Online-Ressource  |w (DE-627)300897308  |w (DE-600)1483522-8  |w (DE-576)094142033  |x 1879-0720  |7 nnas  |a A follow-up report on potential drug interactions with clementines two single case experiments show no effect on CYP3A-dependent midazolam clearance 
773 1 8 |g volume:133  |g year:2019  |g pages:54-58  |g extent:5  |a A follow-up report on potential drug interactions with clementines two single case experiments show no effect on CYP3A-dependent midazolam clearance 
856 4 0 |u https://doi.org/10.1016/j.ejps.2019.03.013  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190814 
993 |a Article 
994 |a 2019 
998 |g 1050230906  |a Weiß, Johanna  |m 1050230906:Weiß, Johanna  |d 910000  |d 910100  |e 910000PW1050230906  |e 910100PW1050230906  |k 0/910000/  |k 1/910000/910100/  |p 7  |y j 
998 |g 1022867652  |a Schwenger, Vedat  |m 1022867652:Schwenger, Vedat  |d 50000  |e 50000PS1022867652  |k 0/50000/  |p 4 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 110903137  |a Mikus, Gerd  |m 110903137:Mikus, Gerd  |d 910000  |d 910100  |e 910000PM110903137  |e 910100PM110903137  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1018788999  |a Hohmann, Nicolas  |m 1018788999:Hohmann, Nicolas  |d 910000  |d 910100  |e 910000PH1018788999  |e 910100PH1018788999  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1671404386  |e 3507036436 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Hohmann, Nicolas","given":"Nicolas","family":"Hohmann","role":"aut"},{"given":"Gerd","display":"Mikus, Gerd","family":"Mikus","role":"aut"},{"given":"Walter E.","display":"Haefeli, Walter E.","role":"aut","family":"Haefeli"},{"role":"aut","family":"Schwenger","display":"Schwenger, Vedat","given":"Vedat"},{"given":"Johanna","display":"Weiß, Johanna","role":"aut","family":"Weiß"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1993 -"],"titleAlt":[{"title":"Pharmaceutical sciences"}],"note":["Gesehen am 25.05.2020","Ungezählte Beil.: Supplement"],"title":[{"title":"European journal of pharmaceutical sciences","title_sort":"European journal of pharmaceutical sciences","subtitle":"official journal of the European Federation for Pharmaceutical Sciences"}],"recId":"300897308","id":{"eki":["300897308"],"zdb":["1483522-8"],"issn":["1879-0720"]},"origin":[{"dateIssuedDisp":"1993-","dateIssuedKey":"1993","publisherPlace":"New York, NY [u.a.]","publisher":"Elsevier"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"A follow-up report on potential drug interactions with clementines two single case experiments show no effect on CYP3A-dependent midazolam clearanceEuropean journal of pharmaceutical sciences","language":["eng"],"part":{"volume":"133","pages":"54-58","extent":"5","text":"133(2019), Seite 54-58","year":"2019"}}],"physDesc":[{"extent":"5 S."}],"name":{"displayForm":["Nicolas Hohmann, Gerd Mikus, Walter Emil Haefeli, Vedat Schwenger, Giuseppe Gattuso, Davide Barreca, Johanna Weiss"]},"id":{"eki":["1671404386"],"doi":["10.1016/j.ejps.2019.03.013"]},"recId":"1671404386","note":["Gesehen am 14.08.2019"],"title":[{"subtitle":"two single case experiments show no effect on CYP3A-dependent midazolam clearance","title":"A follow-up report on potential drug interactions with clementines","title_sort":"follow-up report on potential drug interactions with clementines"}],"language":["eng"],"origin":[{"dateIssuedDisp":"15 May 2019","dateIssuedKey":"2019"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a HOHMANNNICFOLLOWUPRE1520